RN7SKP282

Across TCGA pan-cancer cohorts, RN7SKP282 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RN7SKP282 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RN7SKP282 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SKP282 expression acts as an unfavorable survival marker.

READ, THCA, and BRCA are the cancer types where RN7SKP282 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	III,IV	0.141	0.777	<.001	72	view →
THCA	DFS	Tertile	All	0.572	0.935	<.001	72	view →
BRCA	OS	Tertile	All	0.640	0.925	<.001	60	view →
LUAD	OS	Tertile	All	0.235	0.697	.010	30	view →
CESC	OS	Tertile	All	0.095	0.585	.038	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RN7SKP282–READ (DFS)

Open the READ breakdown →